Stem Cell Therapy for Arthritis

Arthritis is a disease of the musculoskeletal system in which the joints are affected. In the early stages, the patient suffers from pain, difficulty walking, and limitation of usual activities. Progression of the disease leads to worsening of quality of life, and in the long term to patient disability.

Conservative therapy for arthritis is just symptomatic treatment that consists of non-steroidal and steroidal anti-inflammatory drugs, as well as heavy painkillers that have side effects and do not always bring relief. These drugs may just reduce pain, and temporally eliminate inflammation in the joints, but they do not assist in the recovery of the affected tissues, as stem cells can do.

Using cell products for the treatment of arthritis is a proven good alternative in cases if:

  • the main drug therapy is ineffective;
  • there is a need to reduce dependence on these drugs;
  • there is a need to delay or even avoid joint replacement in advanced cases.
Osteoporosis of the knee joint. Medically accurate 3D illustration.

In this article, you will learn what effects can be expected of stem cell treatment for arthritis, how it works and how it is performed, and about the recovery and the after-therapy with cell products. You will also learn about the experiences of previous patients who underwent our cell therapy.

What are the effects of using stem cells to treat arthritis?

Using cell products based on multipotent mesenchymal stromal cells (MMSCs) as a method of arthritis therapy gives a chance to reverse the symptoms (pain, swelling, local redness, stiffness and restriction of movements) and improve the function of damaged joints.

In the therapy, MMSCs are the cells that:

  • improve the overall regenerative potential of the body, triggering the healing process;
  • provide a local and systemic anti-inflammatory effect, which reduces inflammation and pain;
  • activate the patient’s own stem cells which may result in the repair of the joint tissues and to the recovery of their function.

As MMSCs have anti-inflammatory and immunomodulatory effects, the use of these cells can slow or stop the progression of diseases, associated with tissue damage, including autoimmune diseases (such as rheumatoid arthritis). Stem cell therapy enhances immunity decreasing common causes of joint damage.

What results can be achieved through the use of cell-based products?

When introduced to the patient’s body, MMSCs actively produce growth and anti-inflammatory factors – special protein molecules that are able to:

  1. Relieve inflammation, so the pain and the swelling pass or become less pronounced.
  1. Stimulate the growth of capillary networks, which helps to improve the condition of cartilage tissue.

This helps reduce the symptoms and causes of remission, improves the mobility of the affected joints and eliminates discomfort when moving, raising both the patient’s health and overall quality of life.

Here is what our patients report about the treatment:

Roger S., from the United Kingdom:

“I have had pretty bad chronic knee pain in both knees and it’s gone worse over the last years. I had arthroscopies on my both knees and that helped me for a little while but then it got worse. I needed to get 2 knees replacement. My friend told me about a good experience of using stem cell treatment and then I contacted Swiss Medica. I was very nervous and afraid when I arrived. I had stem cell treatment and passed some physiotherapy and already my knees are a lot better.”

Stem Cell Treatment for Arthritic Knees

Patient from Manchester, England:

“I’m 59 and within the last several years I had 3 cartilage removal because of the problems with my knees. After the last surgery, I was told that there was no cartilage left so I had to get a knee replacement soon. I had problems with walking, I couldn’t fully bend my knees, it was always painful. I was receiving stem cells taken from my pelvis and from my fat tissue. I also passed physiotherapy. Initially, I have a lot better movement in my knees, and walking upstairs is not painful now, and the swelling has gone. It feels like 70-80% better.“

Osteoarthritis Stem Cells Treatment UK Patient

What is the source of stem cells for arthritis treatment?

In the case of autologous cell products, MMCSs are derived from the patient’s own adipose tissue or bone marrow. MMSCs derived from adipose tissue have the highest chondrogenic potential. Harvesting from own patient fat is also a less invasive procedure. Despite this, it is possible to get stem cells from the patient’s bone marrow.

In order for the effect to be maximized, the decision on the source of the cells is made by the doctor depending on the patient’s condition and the expected efficiency of the cells.

If there are any contraindications for autologous cells harvesting, or the therapy should commence immediately, we use allogeneic (donor) cell products based on cells derived from healthy donor tissues with a higher therapeutic potential. It is known that the properties of this type of cells are almost the same regardless of whether they are derived from the patient or a donor.

Why do we use stem cells?

Multipotent mesenchymal stem cells have the unique ability to transform into other cells in tissues (i.e. differentiate) and the ability to reproduce themselves. The special value of stem cell therapy is its capacity to stimulate joint regeneration and restoration by stimulating the growth of the cells in the damaged area and regenerating the tissue.

Stem cell therapy for arthritis. Injection of stem cells into the knee (intra-articular administration).

When stem cells are injected directly into the affected joint, they improve its tissue, normalize metabolism, and improve local trophicity, which leads to a reduction of inflammation and recovery of joint mobility.

If possible, it is better to start this treatment early on, before irreversible deformation of the joint has happened. According to the research, early repair of cartilage lesions slows down the progression of osteoarthritis.

How is the procedure performed?

During our treatment, patients receive activated autologous mesenchymal stem cells and/or stromal-vascular fraction (SVF), which is also rich on MMSCs. Afterwards, they are separated and cultivated. The optimal therapeutic dose of cells is calculated according to the patient’s weight.

Cultivating stem cells at the Swiss Medica laboratory.

Then finally cells are returned to the patient’s body by two routes of administration: local injections to the affected joint and IV dip.

The entire procedure can be completed within a few hours. It is absolutely painless, fast, simple, and most importantly safe.

The treatment period takes from 1 to 14 days, according to the patient’s state and expectations, his or her analyses and disease history.

If you want to find out more details about stem cell therapy and about the procedure, please contact our Medical Advisor to get complete information about expected results, the duration of the program and its cost.

Get a free online consultation

Contact us to learn about the expected results of the treatment, its cost and duration.

Dr. Aleksandra Fetyukhina
Dr. Aleksandra Fetyukhina, MD

Medical Advisor, Swiss Medica doctor

Additional treatments for arthritis that helps increase the effect of stem cells

In addition to stem cell injections for arthritis, we approach methods that allow you to get a high recovery rate.

A Swiss Medica traumatologist prepares a daily joint treatment program. This is a special set of exercises + additional treatment methods to relieve pain and improve the functioning of the affected joint, including:

Arthritis with Spark Wave

These types of therapy have an anti-inflammatory effect, ease the disease course, help to form new muscular fibers, stimulate angiogenesis (growth of new blood vessels), and activate the healing work of injected stem cells in the affected area.

After the treatment of arthritis with stem cells

When stem cells are introduced to the patient’s body, improvements gradually accumulate over the next several months. During this period, the patient feels a surge of strength, as the inflammation decreases and the pain goes away. The volume of tolerated physical activity increases. Symptoms may decrease or even reverse, which is possible only with cell therapy.

The maximum time of circulation of stem cells after administration in the body is about half a year. In General, the introduction of stem cells has a systemic positive regenerative effect on the entire body. In particular, healthy joints are more protected after cell therapy (prevention of damage to other joints).

What are the advantages of our treatment system:

  • The high percentage of the recovery.
  • Prevent joints from deterioration.
  • May delay or avoid surgery (joint replacement).
  • A natural way to treat arthritis without the use of chemical drugs.
  • Safety (no side effects).
  • Fewer contraindications.
  • Avoidance of any allergic and immune reactions.
  • Quick and simple (harvesting and the introduction may be performed within a single procedure).
  • Does not require general anesthesia.
  • The procedure is well tolerated at any age.
At Swiss Medica's inpatient clinic
At one of the Swiss Medica inpatient stem cell treatment clinics.

The final effect of stem cell therapy depends on the stage of the pathological process, the disease activity, the recovery abilities of the body and other individual features. However, as our practice shows, improvement occurs in most cases.

Contact us

You can contact our Medical Advisor to find out about the expected results of stem cell treatment according to your case, its cost, duration, and some other details.

Dr. Aleksandra Fetyukhina
Dr. Aleksandra Fetyukhina, MD

Medical Advisor, Swiss Medica doctor

List of References

  1. MicroRNA profiling reveals age-dependent differential expression of nuclear factor κB and mitogen-activated protein kinase in adipose and bone marrow-derived human mesenchymal stem cells. Pandey A.C., Semon J.A., Kaushal D. et al. Stem Cell Research & Therapy 2011;2(6): 49.

  2. Multilineage potential of adult human mesenchymal stem cells. Pittenger MF, Mackay AM, Beck SC, et al. Science. 1999;284:143-147.

  3. Isolation of adipose-derived stem cells and their induction to a chondrogenic phenotype. Estes BT, Diekman BO, Gimble JM, Guilak F. Nat Protoc. 2010;5:1294-1311.

  4. The advancing field of cell based therapy: insights and lessons from clinical trials. Telukuntla K.S., Suncion V.Y., Schulman I.H., Hare J.M. Journal of the American Heart Association 2013;2(5):e000338.

  5. National Academies Press. Understanding Stem Cells. An overview of the Science and Issues from National Academies.

  6. Stem Cells for Temporomandibular Joint Repair and Regeneration. Zhang S et al. Stem Cell Rev. (2015).

  7. Cartilage repair: generations of autologous chondrocyte transplantation. Marlovits S, Zeller P, Singer P, Resinger C, Vecsei V. Eur J Radiol. 2006;57:24-31.

  8. Limited evidence for adipose-derived stem cell therapy on the treatment of osteoarthritis. Hurley ET, Yasui Y, Gianakos AL, Seow D, Shimozono Y, Kerkhoffs GMMJ, Kennedy JG.

  9. Immunosuppressive properties of mesenchymal stem cells: advances and applications. De Miguel M.P., Fuentes-Julian S., Blazquez-Martinez A. et al. Current Molecular Medicine. 2012; 12(5):574–591.

More sources

Medical Advisor, Swiss Medica doctor

May interest you


We use cookies on our site to ensure that we give you the best browsing experience. By continuing to browse the site, you agree to this use. For more information on how we use cookies, see our Cookie Policy and Privacy Policy.

Got it